Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-15

Clinical Trial Update: Investigating the Effect of Intravenous and Oral Tranexamic Acid on Blood Loss After Primary Hip and Knee Arthroplasty [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the effect of intravenous and oral tranexamic acid on blood loss after primary hip and knee arthroplasty has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Belfast Health and Social Care Trust | Conditions: Primary Total Knee Arthroplasty, Primary Total Hip Arthroplasty | Phase 4 | Status: COMPLETED